Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taohong Dieda Fengshi plaster is a traditional Chinese medicine (TCM) hospital-made preparation developed by the Guangzhou Panyu District Traditional Chinese Medicine Hospital. It is primarily indicated for the treatment of knee osteoarthritis (KOA) and related conditions characterized by blood stasis and wind-dampness in TCM theory. The formulation typically contains botanical ingredients such as *Prunus persica* (Peach Kernel) and *Carthamus tinctorius* (Safflower), which are known for their blood-activating and stasis-resolving properties. The plaster is applied topically to the affected joint to alleviate pain, reduce swelling, and improve mobility by promoting local blood circulation and exerting anti-inflammatory effects. As a hospital-made preparation, its use is generally restricted to the developing institution and its affiliated clinical network.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Taohong Dieda Fengshi plaster.